Vpu-mediated counteraction of tetherin is a major determinant of HIV-1 interferon resistance

mBio

Volumn 7, Issue 4, 2016, Pages

  Kmiec, Dorota ^a   Iyer, Shilpa S ^b,c   Stürzel, Christina M ^a   Sauter, Daniel ^a   Hahn, Beatrice H ^b,c   Kirchhoff, Frank ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; CD1D ANTIGEN; CD4 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; TETHERIN; UNCLASSIFIED DRUG; VPU PROTEIN; BST2 PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; LEUKOCYTE ANTIGEN; VIRAL PROTEIN; VPU PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

ARTICLE; CD4+ T LYMPHOCYTE; CELL FREE SYSTEM; CONTROLLED STUDY; ENZYME REPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 GROUP M; HUMAN IMMUNODEFICIENCY VIRUS 1 GROUP N; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; VIRION; VIRUS GENE; VIRUS RELEASE; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION; VPU GENE; ANTAGONISTS AND INHIBITORS; CELL CULTURE; DNA MUTATIONAL ANALYSIS; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE EVASION; IMMUNOLOGY; METABOLISM; PATHOGENICITY; VIROLOGY;

ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DNA MUTATIONAL ANALYSIS; GPI-LINKED PROTEINS; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; IMMUNE EVASION; INTERFERONS; VIRAL REGULATORY AND ACCESSORY PROTEINS;

EID: 84986556429     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00934-16     Document Type: Article

References (49)

1. Sharp PM, Hahn BH. 2011. Origins of HIV and the AIDS pandemic. Cold Spring Harb Perspect Med 1:a006841. http://dx.doi.org/10.1101/cshperspect.a006841.
2. Mourez T, Simon F, Plantier JC. 2013. Non-M variants of human immunodeficiency virus type 1. Clin Microbiol Rev 26:448–461. http://dx.doi.org/10.1128/CMR.00012-13.
3. Delaugerre C, De Oliveira F, Lascoux-Combe C, Plantier JC, Simon F. 2011. HIV-1 group N: travelling beyond Cameroon. Lancet 378:1894. http://dx.doi.org/10.1016/S0140-6736(11)61457-8.
4. Vallari A, Holzmayer V, Harris B, Yamaguchi J, Ngansop C, Makamche F, Mbanya D, Kaptué L, Ndembi N, Gürtler L, Devare S, Brennan CA. 2011. Confirmation of putative HIV-1 group P in Cameroon. J Virol 85: 1403–1407. http://dx.doi.org/10.1128/JVI.02005-10.
5. Sauter D, Schindler M, Specht A, Landford WN, Münch J, Kim KA, Votteler J, Schubert U, Bibollet-Ruche F, Keele BF, Takehisa J, Ogando Y, Ochsenbauer C, Kappes JC, Ayouba A, Peeters M, Learn GH, Shaw G, Sharp PM, Bieniasz P, Hahn BH, Hatziioannou T, Kirchhoff F. 2009. Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe 6:409–421. http://dx.doi.org/10.1016/j.chom.2009.10.004.
6. Neil SJ, Zang T, Bieniasz PD. 2008. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451:425–430. http://dx.doi.org/10.1038/nature06553.
7. Van Damme N, Goff D, Katsura C, Jorgenson RL, Mitchell R, Johnson MC, Stephens EB, Guatelli J. 2008. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 3:245–252. http://dx.doi.org/10.1016/j.chom.2008.03.001.
8. Jia B, Serra-Moreno R, Neidermyer W, Rahmberg A, Mackey J, Fofana IB, Johnson WE, Westmoreland S, Evans DT. 2009. Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. PLoS Pathog 5:e1000429. http://dx.doi.org/10.1371/journal.ppat.1000429.
9. Zhang F, Wilson SJ, Landford WC, Virgen B, Gregory D, Johnson MC, Munch J, Kirchhoff F, Bieniasz PD, Hatziioannou T. 2009. Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe 6:54–67. http://dx.doi.org/10.1016/j.chom.2009.05.008.
10. Gupta RK, Towers GJ. 2009. A tail of Tetherin: how pandemic HIV-1 conquered the world. Cell Host Microbe 6:393–395. http://dx.doi.org/10.1016/j.chom.2009.11.002.
11. Sauter D, Specht A, Kirchhoff F. 2010. Tetherin: holding on and letting go. Cell 141:392–398. http://dx.doi.org/10.1016/j.cell.2010.04.022.
12. Sauter D, Unterweger D, Vogl M, Usmani SM, Heigele A, Kluge SF, Hermkes E, Moll M, Barker E, Peeters M, Learn GH, Bibollet-Ruche F, Fritz JV, Fackler OT, Hahn BH, Kirchhoff F. 2012. Human tetherin exerts strong selection pressure on the HIV-1 group N Vpu protein. PLoS Pathog 8:e1003093. http://dx.doi.org/10.1371/journal.ppat.1003093.
13. Kluge SF, Mack K, Iyer SS, Pujol FM, Heigele A, Learn GH, Usmani SM, Sauter D, Joas S, Hotter D, Bibollet-Ruche F, Plenderleith LJ, Peeters M, Geyer M, Sharp PM, Fackler OT, Hahn BH, Kirchhoff F. 2014. Nef proteins of epidemic HIV-1 group O strains antagonize human tetherin. Cell Host Microbe 16:639–650. http://dx.doi.org/10.1016/j.chom.2014.10.002.
14. Sauter D, Hué S, Petit SJ, Plantier JC, Towers GJ, Kirchhoff F, Gupta RK. 2011. HIV-1 group P is unable to antagonize human tetherin by Vpu, Env or Nef. Retrovirology 8:103. http://dx.doi.org/10.1186/1742-4690-8-103.
15. Yang SJ, Lopez LA, Exline CM, Haworth KG, Cannon PM. 2011. Lack of adaptation to human tetherin in HIV-1 group O and P. Retrovirology 8:78. http://dx.doi.org/10.1186/1742-4690-8-78.
16. Lim ES, Malik HS, Emerman M. 2010. Ancient adaptive evolution of tetherin shaped the functions of Vpu and Nef in human immunodeficiency virus and primate lentiviruses. J Virol 84:7124–7134. http://dx.doi.org/10.1128/JVI.00468-10.
17. Skasko M, Wang Y, Tian Y, Tokarev A, Munguia J, Ruiz A, Stephens EB, Opella SJ, Guatelli J. 2012. HIV-1 Vpu protein antagonizes innate restriction factor BST-2 via lipid-embedded helix-helix interactions. J Biol Chem 287:58–67. http://dx.doi.org/10.1074/jbc.M111.296772.
18. Vigan R, Neil SJ. 2011. Separable determinants of subcellular localization and interaction account for the inability of group O HIV-1 Vpu to counteract tetherin. J Virol 85:9737–9748. http://dx.doi.org/10.1128/JVI.00479-11.
19. Sauter D, Hotter D, Van Driessche B, Stürzel CM, Kluge SF, Wildum S, Yu H, Baumann B, Wirth T, Plantier JC, Leoz M, Hahn BH, Van Lint C, Kirchhoff F. 2015. Differential regulation of NF-βBmediated proviral and antiviral host gene expression by primate lentiviral Nef and Vpu proteins. Cell Rep 10:586–599. http://dx.doi.org/10.1016/j.celrep.2014.12.047.
20. Shah AH, Sowrirajan B, Davis ZB, Ward JP, Campbell EM, Planelles V, Barker E. 2010. Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu. Cell Host Microbe 8:397–409. http://dx.doi.org/10.1016/j.chom.2010.10.008.
21. Moll M, Andersson SK, Smed-Sörensen A, Sandberg JK. 2010. Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments. Blood 116: 1876–1884. http://dx.doi.org/10.1182/blood-2009-09-243667.
22. Neil SJ, Sandrin V, Sundquist WI, Bieniasz PD. 2007. An interferonalpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein. Cell Host Microbe 2:193–203. http://dx.doi.org/10.1016/j.chom.2007.08.001.
23. Sato K, Misawa N, Fukuhara M, Iwami S, An DS, Ito M, Koyanagi Y. 2012. Vpu augments the initial burst phase of HIV-1 propagation and downregulates BST2 and CD4 in humanized mice. J Virol 86:5000–5013. http://dx.doi.org/10.1128/JVI.07062-11.
24. Dave VP, Hajjar F, Dieng MM, Haddad É, Cohen ÉA. 2013. Efficient BST2 antagonism by Vpu is critical for early HIV-1 dissemination in humanized mice. Retrovirology 10:128. http://dx.doi.org/10.1186/1742-4690-10-128.
25. Ochsenbauer C, Edmonds TG, Ding H, Keele BF, Decker J, Salazar MG, Salazar-Gonzalez JF, Shattock R, Haynes BF, Shaw GM, Hahn BH, Kappes JC. 2012. Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages. J Virol 86: 2715–2728. http://dx.doi.org/10.1128/JVI.06157-11.
26. Bodelle P, Vallari A, Coffey R, McArthur CP, Beyeme M, Devare SG, Schochetman G, Brennan CA. 2004. Identification and genomic sequence of an HIV type 1 group N isolate from Cameroon. AIDS Res Hum Retroviruses 20:902–908. http://dx.doi.org/10.1089/0889222041725262.
27. Galão RP, Le Tortorec A, Pickering S, Kueck T, Neil SJ. 2012. Innate sensing of HIV-1 assembly by tetherin induces NF_B-dependent proinflammatory responses. Cell Host Microbe 12:633–644. http://dx.doi.org/10.1016/j.chom.2012.10.007.
28. Pickering S, Hué S, Kim EY, Reddy S, Wolinsky SM, Neil SJ. 2014. Preservation of tetherin and CD4 counter-activities in circulating Vpu alleles despite extensive sequence variation within HIV-1 infected individuals. PLoS Pathog 10:e1003895. http://dx.doi.org/10.1371/journal.ppat.1003895.
29. Wildum S, Schindler M, Münch J, Kirchhoff F. 2006. Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection. J Virol 80:8047–8059. http://dx.doi.org/10.1128/JVI.00252-06.
30. Mehandru S, Poles MA, Tenner-Racz K, Horowitz A, Hurley A, Hogan C, Boden D, Racz P, Markowitz M. 2004. Primary HIV-1 infection is associated with preferential depletion of CD4_ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 200:761–770. http://dx.doi.org/10.1084/jem.20041196.
31. Fenton-May AE, Dibben O, Emmerich T, Ding H, Pfafferott K, Aasa-Chapman MM, Pellegrino P, Williams I, Cohen MS, Gao F, Shaw GM, Hahn BH, Ochsenbauer C, Kappes JC, Borrow P. 2013. Relative resistance of HIV-1 founder viruses to control by interferon-alpha. Retrovirology 10:146. http://dx.doi.org/10.1186/1742-4690-10-146.
32. Parrish NF, Gao F, Li H, Giorgi EE, Barbian HJ, Parrish EH, Zajic L, Iyer SS, Decker JM, Kumar A, Hora B, Berg A, Cai F, Hopper J, Denny TN, Ding H, Ochsenbauer C, Kappes JC, Galimidi RP, West AP, Bjorkman PJ, Wilen CB, Doms RW, O’Brien M, Bhardwaj N, Borrow P, Haynes BF, Muldoon M, Theiler JP, Korber B, Shaw GM, Hahn BH. 2013. Phenotypic properties of transmitted founder HIV-1. Proc Natl Acad Sci U S A 110:6626–6633. http://dx.doi.org/10.1073/pnas.1304288110.
33. Jafari M, Guatelli J, Lewinski MK. 2014. Activities of transmitted/founder and chronic clade B HIV-1 Vpu and a C-terminal polymorphism specifically affecting virion release. J Virol 88:5062–5078. http://dx.doi.org/10.1128/JVI.03472-13.
34. Mlcochova P, Apolonia L, Kluge SF, Sridharan A, Kirchhoff F, Malim MH, Sauter D, Gupta RK. 2015. Immune evasion activities of accessory proteins Vpu, Nef and Vif are conserved in acute and chronic HIV-1 infection. Virology 482:72–78. http://dx.doi.org/10.1016/j.virol.2015.03.015.
35. Ross TM, Oran AE, Cullen BR. 1999. Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein. Curr Biol 9:613–621. http://dx.doi.org/10.1016/S0960-9822(99)80283-8.
36. Argañaraz ER, Schindler M, Kirchhoff F, Cortes MJ, Lama J. 2003. Enhanced CD4 down-modulation by late stage HIV-1 nef alleles is associated with increased Env incorporation and viral replication. J Biol Chem 278:33912–33919. http://dx.doi.org/10.1074/jbc.M303679200.
37. Levesque K, Zhao YS, Cohen EA. 2003. Vpu exerts a positive effect on HIV-1 infectivity by down-modulating CD4 receptor molecules at the surface of HIV-1-producing cells. J Biol Chem 278:28346–28353. http://dx.doi.org/10.1074/jbc.M300327200.
38. Li M, Ablan SD, Miao C, Zheng YM, Fuller MS, Rennert PD, Maury W, Johnson MC, Freed EO, Liu SL. 2014. TIM-family proteins inhibit HIV-1 release. Proc Natl Acad Sci U S A 111:E3699–E3707. http://dx.doi.org/10.1073/pnas.1404851111.
39. Barreto-de-Souza V, Arakelyan A, Margolis L, Vanpouille C. 2014. HIV-1 vaginal transmission: cell-free or cell-associated virus? Am J Reprod Immunol 71:589–599. http://dx.doi.org/10.1111/aji.12240.
40. Sagar M. 2014. Origin of the transmitted virus in HIV infection: infected cells versus cell-free virus. J Infect Dis 210(Suppl 3):S667–S673. http://dx.doi.org/10.1093/infdis/jiu369.
41. Butler DM, Smith DM, Cachay ER, Hightower GK, Nugent CT, Richman DD, Little SJ. 2008. Herpes simplex virus 2 serostatus and viral loads of HIV-1 in blood and semen as risk factors for HIV transmission among men who have sex with men. AIDS 22:1667–1671. http://dx.doi.org/10.1097/QAD.0b013e32830bfed8.
42. Rousseau CM, Nduati RW, Richardson BA, John-Stewart GC, Mbori-Ngacha DA, Kreiss JK, Overbaugh J. 2004. Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission. J Infect Dis 190:1880–1888. http://dx.doi.org/10.1086/425076.
43. Stürmer M, Doerr HW, Berger A, Gute P. 2008. Is transmission of HIV-1 in non-viraemic serodiscordant couples possible? Antivir Ther 13: 729–732.
44. Roques P, Robertson DL, Souquière S, Apetrei C, Nerrienet E, Barré-Sinoussi F, Müller-Trutwin M, Simon F. 2004. Phylogenetic characteristics of three new HIV-1 N strains and implications for the origin of group N. AIDS 18:1371–1381. http://dx.doi.org/10.1097/01.aids.0000125990.86904.28.
45. Simon F, Mauclère P, Roques P, Loussert-Ajaka I, Müller-Trutwin MC, Saragosti S, Georges-Courbot MC, Barré-Sinoussi F, Brun-Vézinet F. 1998. Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat Med 4:1032–1037. http://dx.doi.org/10.1038/2017.
46. Yamaguchi J, McArthur CP, Vallari A, Coffey R, Bodelle P, Beyeme M, Schochetman G, Devare SG, Brennan CA. 2006. HIV-1 group N: evidence of ongoing transmission in Cameroon. AIDS ResHumRetroviruses 22:453–457. http://dx.doi.org/10.1089/aid.2006.22.453.
47. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, Martin MA. 1986. Production of acquired immunodeficiency syndromeassociated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 59:284–291.
48. Schindler M, Münch J, Kutsch O, Li H, Santiago ML, Bibollet-Ruche F, Müller-Trutwin MC, Novembre FJ, Peeters M, Courgnaud V, Bailes E, Roques P, Sodora DL, Silvestri G, Sharp PM, Hahn BH, Kirchhoff F. 2006. Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 125:1055–1067. http://dx.doi.org/10.1016/j.cell.2006.04.033.
49. Münch J, Rajan D, Schindler M, Specht A, Rücker E, Novembre FJ, Nerrienet E, Müller-Trutwin MC, Peeters M, Hahn BH, Kirchhoff F. 2007. Nef-mediated enhancement of virion infectivity and stimulation of viral replication are fundamental properties of primate lentiviruses. J Virol 81:13852–13864. http://dx.doi.org/10.1128/JVI.00904-07.